Product NDC: | 10742-8144 |
Proprietary Name: | Rohto |
Non Proprietary Name: | Hypromellose, Tetrahydrozoline hydrochloride |
Active Ingredient(s): | 3.5; .5 mg/mL; mg/mL & nbsp; Hypromellose, Tetrahydrozoline hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10742-8144 |
Labeler Name: | The Mentholatum Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part349 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20060824 |
Package NDC: | 10742-8144-1 |
Package Description: | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (10742-8144-1) > 13 mL in 1 BOTTLE, WITH APPLICATOR |
NDC Code | 10742-8144-1 |
Proprietary Name | Rohto |
Package Description | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (10742-8144-1) > 13 mL in 1 BOTTLE, WITH APPLICATOR |
Product NDC | 10742-8144 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Hypromellose, Tetrahydrozoline hydrochloride |
Dosage Form Name | LIQUID |
Route Name | OPHTHALMIC |
Start Marketing Date | 20060824 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | The Mentholatum Company |
Substance Name | HYPROMELLOSES; TETRAHYDROZOLINE HYDROCHLORIDE |
Strength Number | 3.5; .5 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |